Endoscopy devices are medical devices used to examine internal organs for diagnosis of diseases. Endoscopic Hemostasis devices consists of devices employed in the management of Gastrointestinal (GI) bleeding and often acts as the first line of therapy. GlobalData uses proprietary data and analytics to provide a comprehensive report on the endoscopic hemostasis devices devices market, including market shares of different players within Japan. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the endoscopic hemostasis devices market in Japan was Cook Medical followed by Boston Scientific, Olympus, ConMed, ERBE Elektromedizin, Micro-Tech Nanjing, United States Endoscopy Group, Diversatek, Medline Industries and Integra LifeSciences.
Endoscopic Hemostasis Devices are generally classified into mechanical devices (clips, ligation devices, suturing devices, stents), injection devices (injection needles), thermal devices (hemostatic probes, hemostatic forceps, heater probe, argon plasma coagulation, radiofrequency ablation, and cryotherapy) and topical devices (hemostatic spray).
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the endoscopic hemostasis devices devices market within Japan was expected to be over $30m in 2022.
For the latest complete market share analysis of endoscopic hemostasis devices device market in Japan, buy the report here.